BefejeződöttFázis nélkül
MULTICENTER, DOUBLE-ARM, PATIENT AND ASSESSOR-MASKED, PROSPECTIVE, RANDOMIZED CLINICAL TRIAL TO COMPARE VISUAL PERFORMANCE OF NEGATIVE AND NEUTRAL ASPHERIC MONOFOCAL INTRAOCULAR LENSES
A legfontosabb adatok
- Ki végzi
- Milton S. Hershey Medical Center
- Hol
- Hershey (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 80 fő vett részt
- Kezdés
- 2023. júl. 27.
- Befejezés
- 2025. okt. 24.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Neutral Aspheric Monofocal IOL
- Negative Aspheric Monofocal IOL
- A regiszteradat frissítve
- 2026. február 3.
Ki vehet részt
- Életkor
- 18 év – 95 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 25 feltétel megnézéseKevesebb
Ki vehet részt
- Male or female, age 18 or older at the time of study enrollment
- Visually significant cataract in the study eye for which phacoemulsification cataract extraction and posterior chamber IOL implantation is indicated
- Projected postoperative CDVA 0.20 logMAR (Snellen 20/32) or better in the study eye, as determined by an Investigator's medical judgement
- Calculated spherical power targeted at emmetropia at distance in the study eyes
- Calculated IOL power between +5.0 - +34.0 D, inclusive, in both eyes
- Measured keratometric astigmatism less than 1.0 D if against-the-rule or 1.5 D if with-the-rule/oblique
- If wearing rigid gas permeable (RGP) contact lens in the study eye, willingness to discontinue lens wear for ≥ 21 days prior to preoperative biometry
- Availability, willingness, and sufficient cognitive awareness to return for study-required visits and comply with examination procedures
- Willingness to sign the IRB-approved informed consent form (ICF) for study participation
Ki nem vehet részt
- Mature cataract in the study eye that is likely to prolong surgical procedure and/or lead to intraoperative complications prior to attempted IOL implantation
- Planned concomitant ocular procedure during cataract surgery inclusive of glaucoma surgery e.g. MIGS or limbal relaxing incisions
- Any visually significant intraocular media opacity other than cataract in the study eye (as determined by the investigator). Such opacities might include corneal scar or vitreous hemorrhage
- Any condition in the study eye that could affect IOL stability (e.g. pseudoexfoliation, zonular dialysis, evident zonular weakness or dehiscence, etc.)
- History of severe dry eye in the study eye that, in the judgement of the investigator, would impair the ability to obtain reliable study measurements
- History of serious corneal disease (e.g. herpes simplex, herpes zoster keratitis, etc.) in the study eye
- History of any clinically significant retinal pathology or ocular diagnosis in the study eye that could, in the investigator's best judgement, alter or limit final post-operative visual prognosis (e.g. diabetic retinopathy, ischemic disease, macular degeneration, retinal detachment, optic neuropathy, amblyopia, strabismus, aniridia, epiretinal membrane, etc.)
- History of cystoid macular edema in either eye
- History of uveitis in either eye
- Current ocular infection in the study eye
- Presence of uncontrolled systemic disease that could increase operative risk (e.g. diabetes mellitus, mental illness, dementia, clinically significant atopic disease, etc.)
- History of intraocular or corneal surgery in the study eye besides laser peripheral iridotomy (LPI), selective laser trabeculoplasty (SLT), or argon laser trabeculoplasty (ALT)
- Abnormal corneal findings in the study eye (e.g. keratoconus, pellucid marginal degeneration, irregular astigmatism)
- Any anterior segment pathology in the study eye that could significantly affect outcomes (e.g. chronic uveitis, iritis, aniridia, clinically significant corneal dystrophies, etc.)
- Uncontrolled glaucoma in the study eye (per Investigator judgement)
- Unsuitable for study participation for any other reason, as determined by the Investigator's clinical judgement
Helyszínek itt: Egyesült Államok
- Penn State Hershey Medical CenterHershey, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The purpose of this study is to compare the binocular distance, intermediate, and near visual acuity and patient reported outcomes of the Johnson \&Johnson Eyhance and Bausch \& Lomb enVista IOLs.
A teljes eredeti leírásKevesebb
We hypothesize that the Johnson \& Johnson's Eyhance and Bausch \& Lomb enVista IOLs will have similar distance, intermediate, and near visual acuity.
A vizsgálat 2 csoportja
- Johnson & Johnson EyhanceMár használt kezelés, összehasonlításként
This research is being done to investigate how patients see at far, intermediate, and near distances after cataract surgery
Kezelés: Negative Aspheric Monofocal IOL
- Bausch & Lomb enVista.Már használt kezelés, összehasonlításként
This research is being done to investigate how patients see at far, intermediate, and near distances after cataract surgery
Kezelés: Neutral Aspheric Monofocal IOL
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2026. február 3.